Start date
02 Mar 2020
End date
02 Mar 2020
Paris, France

The TAT Congress has firmly established itself as the must-attend forum for all experts focusing on early phase drug development and translational research.

Stakeholders from academia and industry meet with clinicians, researchers and regulators from all around the world to facilitate the development of new anti-cancer treatments and make more options available to patients. 

The TAT Congress series has effectively transformed the landscape of early drug development and you have the opportunity to be a part of a highly influential meeting.

Participating in TAT 2020 will bring you outstanding networking opportunities, enlightening discussions and promising new partnerships.

We hope to see you at TAT 2020!


The Congress will take place at:

Palais des Congrès de Paris
2 Place de la Porte Maillot
75017 Paris



Access the online programme for TAT 2020 – Targeted Anticancer Therapies!



Online registration for individuals is still open. Full registration is now applied.

TAT map block image

Map & Venue

Locate the venue for TAT 2020 on an interactive map

News & Press

Press & Media

Information for media representatives including press accreditation



The abstract submission for TAT 2020 is now closed!



Get in touch with the organisers of ESMO Targeted Anticancer Therapies Congress 2020. Contact details here

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings